Elos Medtech
ISIN: SE0000120776 | Ticker: ELOS | LEI: 529900I5MSNU451FL670
Country: Sweden
We are a committed global solution partner that leverages our capabilities in the U.S., Europe, and China – offering Complete Performance™ and vertical integration to leading medical device companies worldwide.
Our success in the medtech industry starts with our people.
The success of Elos Medtech starts with our people, experts in their respective fields with an uncompromising focus on quality, who listen to your needs and systematically apply our knowledge to develop creative solutions that keep our customers poised for success today and in the future.
A partner who goes above and beyond to meet customer needs.
Medical technologies and markets change very quickly. This makes foresight, flexibility, responsiveness, and meticulous attention to detail are absolutely essential.
1923
Served areaWorldwide
HeadquartersTorsgatan 5B, 41104 Göteborg – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 1,002,035,000.00 | 1,126,397,000.00 | 1,422,908,000.00 |
| Noncurrent Assets | N/A | 667,350,000.00 | 743,316,000.00 | 872,101,000.00 |
| Property Plant And Equipment | N/A | 412,242,000.00 | 469,537,000.00 | 562,386,000.00 |
| Land And Buildings | N/A | 173,883,000.00 | 210,747,000.00 | 243,788,000.00 |
| Machinery | N/A | 144,823,000.00 | 196,438,000.00 | 248,999,000.00 |
| Fixtures And Fittings | N/A | 12,571,000.00 | 16,828,000.00 | 15,855,000.00 |
| Construction In Progress | N/A | 34,917,000.00 | 12,542,000.00 | 23,906,000.00 |
| Goodwill | N/A | 234,869,000.00 | 255,241,000.00 | 290,782,000.00 |
| Other Intangible Assets | N/A | 11,206,000.00 | 9,517,000.00 | 5,846,000.00 |
| Other Noncurrent Receivables | N/A | 433,000.00 | 663,000.00 | 0.00 |
| Deferred Tax Assets | N/A | 903,000.00 | 751,000.00 | 126,000.00 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | 17,000.00 | 17,000.00 | 17,000.00 |
| Current Assets | N/A | 334,685,000.00 | 383,081,000.00 | 550,807,000.00 |
| Inventories | N/A | 158,189,000.00 | 172,500,000.00 | 230,389,000.00 |
| Raw Materials | N/A | 42,438,000.00 | 50,888,000.00 | 63,777,000.00 |
| Work In Progress | N/A | 43,681,000.00 | 54,671,000.00 | 62,234,000.00 |
| Finished Goods | N/A | 72,070,000.00 | 66,941,000.00 | 104,378,000.00 |
| Trade And Other Current Receivables | N/A | 88,043,000.00 | 115,449,000.00 | 151,696,000.00 |
| Other Current Receivables | N/A | 3,878,000.00 | 4,263,000.00 | 6,135,000.00 |
| Current Tax Assets Current | N/A | 3,118,000.00 | 5,452,000.00 | 5,698,000.00 |
| Cash and cash equivalents | 55,172,000.00 | 88,453,000.00 | 95,132,000.00 | 168,722,000.00 |
| Current Prepayments And Other Current Assets | N/A | N/A | 9,156,000.00 | 17,626,000.00 |
| Equity And Liabilities | N/A | 1,002,035,000.00 | 1,126,397,000.00 | 1,422,908,000.00 |
| Equity | 539,911,000.00 | 540,298,000.00 | 634,432,000.00 | 798,485,000.00 |
| Issued Capital | N/A | 50,425,000.00 | 50,425,000.00 | 50,425,000.00 |
| Retained Earnings | N/A | 343,562,000.00 | 404,273,000.00 | 500,613,000.00 |
| Share Premium | N/A | 145,511,000.00 | 145,511,000.00 | 145,511,000.00 |
| Other Reserves | N/A | 800,000.00 | 34,223,000.00 | 101,936,000.00 |
| Noncurrent Liabilities | N/A | 305,338,000.00 | 316,618,000.00 | 468,997,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 63,508,000.00 | 70,525,000.00 | 45,773,000.00 |
| Deferred Tax Liabilities | N/A | 19,725,000.00 | 28,938,000.00 | 46,291,000.00 |
| Longterm Borrowings | N/A | 222,105,000.00 | 217,155,000.00 | 376,933,000.00 |
| Current Liabilities | N/A | 156,399,000.00 | 175,347,000.00 | 155,426,000.00 |
| Trade And Other Current Payables | N/A | 35,505,000.00 | 40,979,000.00 | 43,850,000.00 |
| Accruals Classified As Current | N/A | 45,233,000.00 | 49,750,000.00 | 62,911,000.00 |
| Other Current Payables | N/A | 22,468,000.00 | 13,389,000.00 | 7,482,000.00 |
| Current Tax Liabilities Current | N/A | 1,914,000.00 | 1,885,000.00 | 17,639,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 580,000,000.00 | 723,581,000.00 | 888,542,000.00 |
| Other Income | 2,021,000.00 | 4,259,000.00 | 4,147,000.00 |
| Profit Loss From Operating Activities | 63,617,000.00 | 101,091,000.00 | 122,396,000.00 |
| Finance Income | 366,000.00 | 7,835,000.00 | 11,877,000.00 |
| Finance Costs | 20,723,000.00 | 10,902,000.00 | 35,170,000.00 |
| Profit Loss Before Tax | 43,260,000.00 | 98,024,000.00 | 99,103,000.00 |
| Income Tax Expense Continuing Operations | 7,228,000.00 | 22,434,000.00 | 24,053,000.00 |
| Profit (loss) | 36,032,000.00 | 75,590,000.00 | 75,050,000.00 |
| Profit Loss Attributable To Owners Of Parent | 36,032,000.00 | 75,590,000.00 | 75,050,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 36,032,000.00 | 75,590,000.00 | 75,050,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | 8,610,000.00 | -7,253,000.00 | -41,583,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 60,035,000.00 | 55,489,000.00 | 66,791,000.00 |
| Other Adjustments For Noncash Items | N/A | 11,252,000.00 | -2,093,000.00 | 8,591,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 10,596,000.00 | 18,242,000.00 | 11,526,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 125,560,000.00 | 104,975,000.00 | 108,278,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 511,000.00 | 122,000.00 | 0.00 |
| Purchase Of Other Longterm Assets Classified As Investing Activities | N/A | 266,000.00 | 0.00 | N/A |
| Cash Flows From Used In Investing Activities | N/A | -56,285,000.00 | -85,438,000.00 | -117,231,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 42,931,000.00 | 60,894,000.00 | 343,564,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 73,410,000.00 | 67,799,000.00 | 269,563,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | 0.00 | 12,102,000.00 | 0.00 |
| Cash Flows From Used In Financing Activities | N/A | -31,320,000.00 | -19,007,000.00 | 74,001,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 37,955,000.00 | 530,000.00 | 65,048,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -4,674,000.00 | 6,149,000.00 | 8,542,000.00 |
| Cash and cash equivalents | 55,172,000.00 | 88,453,000.00 | 95,132,000.00 | 168,722,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 16.11.22 | Ewa Linsäter | Other | Sell | SEK 327,332.00 |
| 16.11.22 | Ewa Linsäter | Other | Sell | SEK 293.00 |
| 15.11.22 | Ewa Linsäter | Other | Sell | SEK 146,000.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 45,600.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 38,125.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 30,600.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 28,272.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 13,680.00 |
| 10.12.21 | Ewa Linsäter | Other | Sell | SEK 1,540.00 |
| 08.12.21 | Ewa Linsäter | Other | Sell | SEK 1,260.00 |
SE0000120776
LEI529900I5MSNU451FL670
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.